🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSwitzerland BAG coverage — 12 month update

Switzerland BAG coverage — 12 month update

SarahChen_PharmD Mon, Feb 2, 2026 at 5:10 PM 29 replies 1,533 viewsPage 1 of 6
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Feb 2, 2026 at 5:10 PM#1

Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the talking.

What I am trying to establish is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work.

Happy to be told the question itself is wrong.

22 17Dr.ObesityLA, NurseKim_ATL, paul_denver and 19 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Feb 2, 2026 at 5:17 PM#2
SarahChen_PharmD said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $206/month (eating less)
  • Restaurants: SAVED $196/month (fewer meals out)
  • Alcohol: SAVED $146/month (stopped drinking)
  • Life insurance: Premium REDUCED by $36/month (lower BMI)
  • Copays: SAVED $56/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

Last edited: Feb 2, 2026 at 7:17 PM
21 16wei_SG, cory_ATX, lori_vegas and 18 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Feb 2, 2026 at 5:24 PM#3
Dr.LipidDallas said:
Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $206/month (eating less) Restaurants: SAVED $196/month…
Dr.LipidDallas said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

Last edited: Feb 2, 2026 at 6:24 PM
20 15TomTeleRx, DoseLogDan, SleepFixSam and 17 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Feb 2, 2026 at 5:31 PM#4
SarahChen_PharmD said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Mine went the same way, slower. Posting only so the count is not one.

Last edited: Feb 2, 2026 at 11:31 PM
19 14SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 16 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Feb 2, 2026 at 6:05 PM#5

From the other side of the consultation, briefly.

SarahChen_PharmD said:
...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

  1. Document medical necessity (BMI, comorbidities, failed alternatives)
  2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
  3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
  4. Request peer-to-peer review between your doctor and the plan's medical director
  5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

18 13NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 15 others
Reply Quote Save Share Report
1236

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register